Adaptive Biotechnologies Corporation Reports Second Quarter 2019 Financial Results
August 13, 2019 16:05 ET
|
Adaptive Biotechnologies
SEATTLE, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT) today reported financial results for the quarter ended June 30, 2019. “At...
Adaptive Biotechnologies Executes Lease for New 100,000 Square Foot Corporate Headquarters, Tripling its Footprint in Seattle’s Growing Biotech Hub
August 07, 2019 08:30 ET
|
Adaptive Biotechnologies
SEATTLE, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:ADPT), a commercial-stage biotechnology company that reads and translates the genetic code of the adaptive...
Adaptive Biotechnologies to Report Second Quarter Financial Results on August 13, 2019
August 01, 2019 16:15 ET
|
Adaptive Biotechnologies
SEATTLE, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies (Nasdaq: ADPT) today announced that it will report financial results for the second quarter of 2019 after market close on Tuesday,...
Adaptive Biotechnologies Receives New York State CLEP Approval for clonoSEQ to Detect and Monitor Minimal Residual Disease (MRD) in Patients with Certain Blood Cancers
July 31, 2019 16:15 ET
|
Adaptive Biotechnologies
SEATTLE, July 31, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:ADPT) (“Adaptive”), a commercial-stage biotechnology company that reads and translates the genetic code of the...
Adaptive Biotechnologies Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
July 01, 2019 16:05 ET
|
Adaptive Biotechnologies
SEATTLE, July 01, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:ADPT) (“Adaptive”), a commercial-stage biotechnology company that reads and translates the genetic code of the...
Adaptive Biotechnologies Announces Pricing of Initial Public Offering
June 26, 2019 19:57 ET
|
Adaptive Biotechnologies
SEATTLE, June 26, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:ADPT) (“Adaptive”), a commercial-stage biotechnology company that reads and translates the genetic code of the...